Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP967996.RACiJnVaJC_fyYiwUIJGdRo2fqZR7X1qM44RLgCoz89q8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP967996.RACiJnVaJC_fyYiwUIJGdRo2fqZR7X1qM44RLgCoz89q8130_assertion type Assertion NP967996.RACiJnVaJC_fyYiwUIJGdRo2fqZR7X1qM44RLgCoz89q8130_head.
- NP967996.RACiJnVaJC_fyYiwUIJGdRo2fqZR7X1qM44RLgCoz89q8130_assertion wasGeneratedBy ECO_0000203 NP967996.RACiJnVaJC_fyYiwUIJGdRo2fqZR7X1qM44RLgCoz89q8130_provenance.
- NP967996.RACiJnVaJC_fyYiwUIJGdRo2fqZR7X1qM44RLgCoz89q8130_assertion wasDerivedFrom befree-2016 NP967996.RACiJnVaJC_fyYiwUIJGdRo2fqZR7X1qM44RLgCoz89q8130_provenance.
- NP967996.RACiJnVaJC_fyYiwUIJGdRo2fqZR7X1qM44RLgCoz89q8130_assertion SIO_000772 22421340 NP967996.RACiJnVaJC_fyYiwUIJGdRo2fqZR7X1qM44RLgCoz89q8130_provenance.
- NP967996.RACiJnVaJC_fyYiwUIJGdRo2fqZR7X1qM44RLgCoz89q8130_assertion evidence source_evidence_literature NP967996.RACiJnVaJC_fyYiwUIJGdRo2fqZR7X1qM44RLgCoz89q8130_provenance.
- NP967996.RACiJnVaJC_fyYiwUIJGdRo2fqZR7X1qM44RLgCoz89q8130_assertion description "[This pattern of effects was consistent with IL6R blockade from infusions of tocilizumab (4-8 mg/kg every 4 weeks) in patients with rheumatoid arthritis studied in randomised trials.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP967996.RACiJnVaJC_fyYiwUIJGdRo2fqZR7X1qM44RLgCoz89q8130_provenance.